FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Medplus Health IPO and Supriya Lifescience IPO.
Medplus Health IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Medplus Health IPO | Supriya Lifescience IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Credit Suisse Securities (India) Private Limited Edelweiss Financial Services Ltd Nomura Financial Advisory And Securities (India) Pvt Ltd |
Axis Capital Limited ICICI Securities Limited |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Medplus Health IPO is up to ₹1,398.30 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Medplus Health IPO is ₹796.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
Medplus Health IPO | Supriya Lifescience IPO | |
---|---|---|
Face Value | ₹2 per share | ₹2 per share |
Issue Price (Lower) | ₹780.00 per share | ₹265.00 per share |
Issue Price (Upper) | ₹796.00 per share | ₹274.00 per share |
Issue Price (Final) | ₹796.00 per share | ₹274.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹78.00 per share | |
Market Lot Size | 18 shares | 54 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹600.00 Cr | up to ₹200.00 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | up to ₹798.30 Cr | up to ₹500.00 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹1,398.30 Cr | up to ₹700.00 Cr |
Medplus Health IPO opens on Dec 13, 2021, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Medplus Health IPO and Supriya Lifescience IPO is Dec 15, 2021, and Dec 20, 2021, respectively.
Medplus Health IPO | Supriya Lifescience IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Dec 13, 2021 | Dec 16, 2021 |
Issue Close | Dec 15, 2021 | Dec 20, 2021 |
Basis Of Allotment (Tentative) | Dec 20, 2021 | Dec 23, 2021 |
Initiation of Refunds (Tentative) | Dec 21, 2021 | Dec 24, 2021 |
Credit of Share (Tentative) | Dec 22, 2021 | Dec 27, 2021 |
Listing date (Tentative) | Dec 23, 2021 | Dec 28, 2021 |
Anchor Lockin End date 1 | Jan 19, 2022 | Jan 22, 2022 |
Anchor Lockin End date 2 | Mar 20, 2022 | Mar 23, 2022 |
Medplus Health IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .
Medplus Health IPO | Supriya Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 43.16% | 99.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 40.43% | 68.24% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Medplus Health IPO retail investors (RII) are offered 62,51,965 shares while in Supriya Lifescience IPO retail investors are offered 62,51,965 shares. Qualified institutional buyers (QIB) are offered 35,72,550 shares in Medplus Health IPO and 79,24,527 shares in Supriya Lifescience IPO.
Medplus Health IPO | Supriya Lifescience IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 35,72,550 shares | 79,24,527 shares |
NII | 26,79,414 shares | 39,62,263 shares |
RII | 62,51,965 shares | 26,41,509 shares |
Employee | 71,225 shares | 0 shares |
Others | ||
Total | 1,25,75,154 shares | 1,45,28,299 shares |
Medplus Health IPO subscribed 52.59x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
Medplus Health IPO | Supriya Lifescience IPO | |
---|---|---|
QIB (times) | 111.90x | 31.83x |
NII (times) | 85.33x | 161.22x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 5.24x | 56.01x |
Employee (times) | 3.05x | |
Other (times) | ||
Total (times) | 52.59x | 71.51x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|